Abstract #1003503: A Phase 2, Interventional, Randomized, Double-Blind, Placebo-Controlled Pilot Study of Glucagon Ready-To-Use in Subjects Who Experience Hyperinsulinemic Hypoglycemia After Bariatric Surgery